bit.bio

bit.bio is a human cell programming company. From its funding announcement.

$25M Series DRaised 5 days agoCambridge, UKOtherUK
Visit website →

In their own words

What bit.bio says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "human cell programming company". Source

Market expansion

Public signal Read from the company's own description of what the funding supports.

Why now

Where bit.bio is today

bit.bio announced a Series D round of $25M on 4 November 2026. AfterRaise has tracked 2 funding events for this company this year, $75M in total.

Latest round
Series D
Amount
$25M
Announced
4 November 2026
Headquarters
Cambridge, UK
Sector
Other
Growth stage
Series C+
Investors
Not stated
Also participating
Not stated
Relevant leadership
CEO Dr. Emma Pepperell

Momentum AfterRaise intelligence

AfterRaise Score

84
High momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
16/25
round size relative to the market
Funding stage
20/20
Series D
Funding cadence
8/15
2 funding events tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 4 November 2026
    $25M Series D
    Investors not stated in the announcement.
  • 12 January 2026
    $50M raised
    Led by M&G Investments.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Accelerated hiring across functions

Opportunities this could create

  • Go-to-market partnerships
  • Market-entry advisers
  • Local employment infrastructure
  • In-market partnerships
  • Commercial leadership

Based on the Other sector, a Series C+ round and the priorities the company itself set out. Not a statement of fact.

Medium momentum3 connected signals across 296 days
  • 4 November 2026$25M Series D announced
  • 12 January 2026Funding round announced
  • 4 November 2026Stated priority: market expansion

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What bit.bio is open to

Not yet specified

bit.bio has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with bit.bio

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at bit.bio?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Other companies

See the sector